METASTATIC COLORECTAL CARCINOMA
Clinical trials for METASTATIC COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail shows promise for Hard-to-Treat colorectal cancer
Disease control CompletedThis early-phase study tested a combination of three drugs—regorafenib, nivolumab, and ipilimumab—in 39 people with advanced colorectal cancer that had spread and was no longer responding to chemotherapy. The goal was to find the safest dose and see if the combination could slow …
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 07:05 UTC
-
New combo therapy shows promise for tough colorectal cancer
Disease control CompletedThis early-phase trial tested a combination of three drugs (utomilumab, cetuximab, and irinotecan) in 34 people with advanced colorectal cancer that had spread. The main goals were to find the safest dose and see if the treatment could shrink tumors. The study is complete, and re…
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:18 UTC